Diffuse Large B-cell Lymphoma Complicated with Anti-3-hydroxy-3-methylglutaryl-Coenzyme A Reductase Immune-mediated Necrotizing Myopathy: A Case Report-Reference-Cited by-同舟云学术

Diffuse Large B-cell Lymphoma Complicated with Anti-3-hydroxy-3-methylglutaryl-Coenzyme A Reductase Immune-mediated Necrotizing Myopathy: A Case Report

Published:2024 Issue: Volume: Page:
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Tokunaga Yoshihiro¹,Akiyama Masaru¹,Nakano Kohei¹,Konaka Kiminori¹,Taguchi Akihiko¹,Maeda Toshihiko²,Sato Ryota²,Kanda Takashi²³,Nakamura Yukinori¹,Yujiri Toshiaki¹⁴,Ohta Yasuharu¹

Affiliation:

1. Department of Endocrinology, Metabolism, Hematological Science and Therapeutics, Yamaguchi University Graduate School of Medicine, Japan

2. Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine, Japan

3. Neuromuscular Center, Yoshimizu Hospital, Japan

4. Department of Laboratory Science, Yamaguchi University Graduate School of Medicine, Japan

Publisher

Japanese Society of Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_3880-24/_pdf

Reference18 articles.

1. 1. Limaye V, Bundell C, Hollingsworth P, et al. Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase in patients with immune-mediated myositis and necrotizing myopathy. Muscle Nerve 52: 196-203, 2015.

2. 2. Watanabe Y, Uruha A, Suzuki S, et al. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy. J Neurol Neurosurg Psychiatry 87: 1038-1044, 2016.

3. 3. Allenbach Y, Keraen J, Bouvier AM, et al. High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody. Brain 139: 2131-2135, 2016.

4. 4. Kadoya M, Hida A, Hashimoto Maeda M, et al. Cancer association as a risk factor for anti-HMGCR antibody-positive myopathy. Neurol Neuroimmunol Neuroinflamm 3: e290, 2016.

5. 5. Tsujikawa K, Hara K, Muro Y, et al. HMGCR antibody-associated myopathy as a paraneoplastic manifestation of esophageal carcinoma. Neurology 87: 841-843, 2016.